Beverly Fishman

Beverly Fishman was born in 1955 in Philadelphia, Pennsylvania.[1] A Guggenheim fellow, she has been artist-in-residence at Cranbrook Academy of Art since 1992, where she is Head of the Painting Department.[2] Her art has been the subject of major reviews by art critics Donald Kuspitt and Jason Stopa in Art in America.[3]

Exhibitions

In 1986 her art was in the show Sydney Blum/Petah Coyne/Beverly Fishman at P.S. 122, New York. In 2002 she had a solo show at Galerie Jean-Luc & Takako Richard, the gallery which was formerly known as Gallery Oz and subsequently known as Galerie Richard. Her solo show Focus: Beverly Fishman was featured at the Eli and Edythe Broad Art Museum at Michigan State University. [4] [5] The exhibition Beverly Fishman: Dose, curated by Nick Cave was exhibited in 2017.[6] In 2018 she exhibited Chemical Sublime at Kavi Gupta Gallery in Chicago.[7]

Dorothy Mayhall published the exhibition catalog for the show Beverly Fishman: Paintings, Drawings and Sculpture, shown November 4 – December 6, 1985 at the Housatonic Museum of Art.

Fishman was interviewed by Leslie Wayne of the online magazine Art Critical about three solo shows: Pain Management at the Library Street Collective in Detroit, Michigan; Another Day in Paradise at the Abroms-Engel Institute for the Visual Arts in Birmingham, Alabama, and Dose, curated by Nick Cave at the CUE Foundation in NYC.[8]

In 2017 Zachary Small reviewed Beverly Fishman: Color Coding Big Pharma for art21 magazine,[9] and she was interviewed by Jason Stopa for Art in America magazine about her abstract art derived from a focus on pill and medication addictions. Stopa wrote that Fishman "creates powerful abstract paintings that address technology and the pharmaceutical industry" and adds, "Fishman is a painter with the concerns of a sculptor, making paintings that require high levels of production. Her studio practice includes manufacturing uniquely shaped supports and consulting with automotive paint specialists to get the background she needs to achieve industrial finishes."[10]

Awards and honors

Fishman received her BFA from Philadelphia College of Art (now the University of the Arts) in 1977. Fishman received her MFA degree from Yale University in 1980.[11] At Yale she studied under Judy Pfaff and Elizabeth Murray. Her work is included in the Hallmark Collection.[12] She was awarded a Guggenheim Fellowship in 2005.

gollark: Why is nobody using my breakthrough?
gollark: I solved indentation SO LONG AGO.
gollark: So apparently neurons' activation thresholds go down locally via ??? and then too many fire.
gollark: ddg! Seizures wikipedia
gollark: ddg! Seizures

References

  1. "Beverly Fishman". www.brunodavidgallery.com. Retrieved 2 June 2017.
  2. "Artist-in-Residence Beverly Fishman - Cranbrook Academy of Art". Cranbrook Academy of Art. Retrieved 1 June 2017.
  3. "Donald Kuspit on Beverly Fishman - artnet Magazine". www.artnet.com. Retrieved 2 June 2017.
  4. "Focus: Beverly Fishman | Eli and Edythe Broad Art Museum at Michigan State University". broadmuseum.msu.edu. Retrieved 1 June 2017.
  5. "Science Spotlight: Beverly Fishman @ The Broad". THE ANNEX. Retrieved 5 June 2017.
  6. ""Beverly Fishman: Dose"". CUE Art Foundation. Retrieved 1 June 2017.
  7. "CHEMICAL SUBLIME – Kavi Gupta Gallery". kavigupta.com. Retrieved 22 March 2018.
  8. Wayne, Leslie (30 March 2017). "The Drug Administration: Beverly Fishman talks High Modernism and Big Pharma". artcritical. Retrieved 1 June 2017.
  9. Small, Zachary (March 21, 2017). "Beverly Fishman: Color-Coding Big Pharma". Art21 Magazine. Retrieved 2 June 2017.
  10. Stopa, Jason. "The Drug of Abstraction: An Interview with Beverly Fishman - Interviews - Art in America". www.artinamericamagazine.com. Retrieved 1 June 2017.
  11. "Artist-in-Residence Beverly Fishman - Cranbrook Academy of Art". Cranbrook Academy of Art. Retrieved 1 June 2017.
  12. "Beverly Fishman | Dividose: Fluor.Y.O.R.G.B. | Hallmark Art Collection". Hallmark Art Collection. Retrieved 5 June 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.